In this analysis presented at the American Academy of Dermatology annual meeting, serious adverse events were low, unrelated ...

Patients with RA who have used b/tsDMARDs demonstrated similar risks for multiple myeloma when compared with those taking only csDMARDs.

in combination with tofacitinib for treating inflammatory bowel disease (IBD) using 3D models and p Renowned gastrointestinal diseases conference to held in Washington, D.C. May 18-21, 2024SAN ...

Insufficient documentation in regard to fetal safety implies the discontinuation of leflunomide, tofacitinib as well as abatacept, rituximab, belimumab, tocilizumab, ustekinumab and anakinra before a ...

Individuals with pemphigus vulgaris treated with low-dose methotrexate in addition to corticosteroids achieved faster reduction in glucocorticoid use compared with patients treated with ...